News

• Investor Relations

Nippon Shokubai Announces Matters Regarding Dividends

• Investor Relations

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019

• Investor Relations

Views and Policy, etc. Regarding Investment Unit Reduction

• Investor Relations

Discontinuation of Countermeasures (Takeover Defense Measures) against Large-Scale Purchase of Nippon Shokubai Shares

• Investor Relations

Nippon Shokubai Announces Matters Regarding Dividends

• Investor Relations

Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019

• Investor Relations

Views and Policy, etc. Regarding Investment Unit Reduction

Nippon Shokubai and Bizen Chemical Signed a Joint Development Agreement on Cosmetic Ingredients Utilized Chestnut Skin Extracts

Nippon Shokubai and Lilac Pharma Signed an Agreement on Business of Liposome Ingredients for Cosmetics

Notice Concerning Voluntary Adoption of International Financial Reporting Standards (IFRS)

• Investor Relations

Summary of Consolidated Financial Results For the Third Quarter of the Fiscal Year Ending March 31, 2019

• Investor Relations

Consolidated Financial Results, 3Q-FY 2018

New Year’s Message to the Employees

• Investor Relations

Financial Results Briefing Material, Q2-FY2018

Shoko Sasaki Wins Japanese LGPA Tour for Two Times in This Season, Winning Third Time in Total

• Investor Relations

Summary of Consolidated Financial Results For the Second Quarter of the Fiscal Year Ending March 31, 2019

• Investor Relations

Consolidated Financial Results, 2Q-FY 2018

ESG Data has been released

CSR Report 2018 has been published

NIPPON SHOKUBAI announces PT. NIPPON SHOKUBAI INDONESIA, a subsidiary in Indonesia (“NSI”), plans to expand its Acrylic Acid (“AA”) plant